UWMDI Co-Director, Michael Schwartz, MD in UW Medicine Newsroom
More study needed into the ‘why’ of new weight-loss drugs Hitting the market over the past six years, the drugs Ozempic, Wegovy and Mounjaro are viewed as a therapeutic breakthrough
Read More